Dutasteride Tablet 0.5 mg
Product Description
YUYU PHARMA
-
KR
-
2023On CPHI since
-
2Certificates
-
250 - 499Employees
Company types
Primary activities
Categories
Specifications
YUYU PHARMA
-
KR
-
2023On CPHI since
-
2Certificates
-
250 - 499Employees
Company types
Primary activities
More Products from YUYU PHARMA (3)
-
Product Calcitriol 1μg
1. Efficacy & Effectiveness
1) Treatment for hypocalcemia in chronic kidney dialysis patients.
2) Improvement of skeletal dysplasia by remarkable reducing elevated parathyroid hormone levels.
2. Administration & Dosage
The initial recommend... -
Product Dutasteride and Tadalafil Tablet 0.5/5 mg
We have developed novel combination of marketed individual Dutasteride and Tadalafil (Avodart + Cialis) for BPH indication. The combination of tadalafil with dutasteride provide better therapeutic effect in improvement of BPH and LUTs symptoms while reduce adverse effect profile particularly Erectile d... -
Product Dutasteride and Tamsulosin HCl Capsules 0.5/0.4 mg
We have developed novel small capsules of marketed Dutasteride and Tamsulosin HCl Capsules (Jalyn/Duodart/Combodart)) for BPH indication. The marketed product is a big pill, 23mm in length above FDA’s recommendation (22mm). Large pill size of marketed product considered burdensome for patients; potenti...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance